Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05091034 · ClinicalTrials.gov registry record · NA

CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents

A NA study of Asthma, sponsored by Columbia University.

Active
Registry status
NA
Development phase
374
Enrollment target
1
Study location

NCT05091034 is a NA study of Asthma that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 374 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05091034, a NA study of Asthma, is active but no longer recruiting, sponsored by Columbia University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
374 participants
Enrollment target
1
Study location

Study Summary

This study will test the efficacy and cost-effectiveness of Controlling Asthma Program for Adolescents (CAMP Air), an e-health intervention, among urban predominately Black and Hispanic adolescents with uncontrolled asthma. It will also examine barriers and facilitators to adoption and implementation of CAMP Air in high-schools.

Conditions Studied

Interventions

  • BEHAVIORAL Controlling Asthma Program for Adolescents (CAMP Air)
  • BEHAVIORAL Attention Control Asthma Education Intervention

Study Locations (1)

New York

  • High schools in the 5 boroughs of New York City - New York

Trial Details

FieldValue
Enrollment Target 374 participants
Start Date 2021-11-08
Est. Completion 2027-06-30
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05091034

The ClinicalTrials.gov registry entry for NCT05091034 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (76% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Controlling Asthma Program for Adolescents (CAMP Air) is the first listed.

NCT05091034 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05091034 about?

NCT05091034 is a clinical study titled "CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents". This study will test the efficacy and cost-effectiveness of Controlling Asthma Program for Adolescents (CAMP Air), an e-health intervention, among urban predominately Black and Hispanic adolescents with uncontrolled asthma. It will also examine barriers and facilitators to adoption and implementatio...

What is the current status of trial NCT05091034?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 374 participants. The study started on 2021-11-08. Estimated completion is 2027-06-30.

What conditions does trial NCT05091034 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT05091034?

The interventions under investigation include: Controlling Asthma Program for Adolescents (CAMP Air) (BEHAVIORAL), Attention Control Asthma Education Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05091034?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05091034 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.